Mitigating fatigue in long COVID patients with MYP^plus: a clinical observation.

ABSTRACT:

Purpose

The COVID-19 pandemic has led to the emergence of a secondary public health crisis known as Long COVID. It is estimated that approximately 10% of individuals who contact COVID-19 develop Long COVID, with fatigue and brain fog being among the most commonly reported and debilitating symptoms. However, no standardized or effective treatments are currently available. This observational study aimed to evaluate the efficacy of MYP^plus, an herbal formulation composed of Astragali Radix, Salviae Radix, and Aquilariae Lignum, in alleviating fatigue and brain fog in patients with Long COVID.

Methods

Subjects with a score of 60 or higher on the Modified Korean version of the Chalder Fatigue scale (mKCFQ11) or a brain fog rating of 5 or higher on the visual analogue s

SUBMITTER: Choi YJ 

PROVIDER: S-EPMC12034194 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature